Definitions of cytomegalovirus infection and disease in transplant recipients.

By P. Ljungman, P. Griffiths, C. Payá. Clinical Infectious Diseases, 2002

1,322 citations recorded by the source corpus.

Subfields: Epidemiology, Surgery, Transplantation

View Paper: https://www.semanticscholar.org/paper/26d13facabd8a32f94d7b82b6710c7b035110b78

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. C. Kotton
2. R. Razonable
3. Deepali Kumar
4. A. Humar
5. A. Caliendo
6. H. Hirsch
7. A. Åsberg
8. S. Chou

Citations in the corpus

• Reduced mortality after allogeneic hematopoietic cell transplantation (2010, neutral): “Myelodysplastic syndrome 174 (12) 230 (20)”
• Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. (2017, methodology): “disease were initially developed and published as part of the proceedings of the Fourth International CMV Conference in Paris in 1993 [1], and these were subsequently updated in 1995 [2] and most recently in 2002 [3].”
• Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. (2013, positive): “The diagnosis of tissue-invasive CMV disease, such as hepatitis and gastrointestinal infection, should be confirmed by immunohistochemistry or in situ DNA hybridization ( 46 Y 48 ).”